OBJ works with major international pharmaceutical and FMCG companies to help them develop new products. This is highly secretive work as these are highly competitive sectors, so OBJ's partners rarely permit them to announce their progress, as that would alert competitors to where these majors are focusing their product development plans.
Imho, it's highly unlikely that anyone would be privy to sensitive information relative to the NDA terms of arrangement between OBJ and P&G, however in defending comments from Mr Boorman, it can really only be appreciated by investors who spare the time required to unlock the true potential of OBJ through rigorous research, and having a good understanding of P&G's Connect+Develop innovation strategy, to acknowledge that by setting up a multiple application structure with P&G provides a platform for many applications across a large number of P&G products which will only evolve over time.
Having already informed the market that OBJ are only working with P&G's global leadership brand portfolio, and deducting from this the four global brands covering the field of skin care which are, Olay, Covergirl, SK-II, and Max Factor, it's a pretty safe but conservative bet to conclude that OBJ will be working with top selling products under the Olay brand.
When one gains a deeper understanding for OBJ's technology offerings for utilizing the “free” energy of normal consumer action in the creation of more efficient products that use fewer chemicals, and appreciates that this addresses one of the key commercial objectives for satisfying the environmental sustainability and social responsibility vision of global FMCG and Pharmaceutical partners, only then will one come to better appreciate the probability of OBJ working with ALL four global skin care brands at P&G, in addition to acknowledging exactly why not one company has walked away from collaborations with OBJ Limited.
There has been talk on the 'bubbles' thread recently about 3M and another major FMCG company, no longer being involved with OBJ Limited - these assumptions are absolutely nonsense...
"We announced to the market initial dealings with 3M and an FMCG with whom we undertook the very successful testing using Azopharma as the agency. The two actions are entirely separate. All of the parties we are dealing with continue to be in contact and some are more active than others. Some partnering companies forge ahead after digesting results, some forge ahead regardless. There is no common thread so I would not be too concerned with your findings." ~ Glyn Denison (2013)
OBJ Price at posting:
7.2¢ Sentiment: LT Buy Disclosure: Held
(20min delay)